Cited by 588Computational Drug Discovery MethodsArtificial Intelligence in Healthcare and EducationMachine Learning in Healthcare

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Digital twins to personalize medicine

Open access

Abstract

Personalized medicine requires the integration and processing of vast amounts of data. Here, we propose a solution to this challenge that is based on constructing Digital Twins. These are high-resolution models of individual patients that are computationally treated with thousands of drugs to find the drug that is optimal for the patient.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13073-019-0701-3

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The digital twin concept for personalized medicine. a An individual patient has a local sign of disease (red). b A digital twin of this patient is constructed in unlimited copies, based on computational network models of thousands of disease-relevant variables. c Each twin is computationally treated with one or more of the thousands of drugs. This results in digital cure of one patient (green). d The drug that has the best effect on the digital twin is selected for treatment of the patient
Fig. 1 The digital twin concept for personalized medicine. a An individual patient has a local sign of disease (red). b A digital twin of this patient is constructed in unlimited copies, based on computational network models of thousands of disease-relevant variables. c Each twin is computationally treated with one or more of the thousands of drugs. This results in digital cure of one patient (green). d The drug that has the best effect on the digital twin is selected for treatment of the patientCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 1

  1. US Food and Drug Administration. Paving the way for personalized medicine: FDA’s role in a new era of medical product development. Silver Spring: US Food and Drug Administration; 2013. https://www.fdanews.com/ext/resources/files/10/10-28-13-Personalized-Medicine.pdf. Accessed 26 Nov 2019.

Cited by

Sorted by citations

Items 301–400 of 588

Metadata

Authors
on behalf of the Swedish Digital Twin Consortium, Björnsson, B., Borrebaeck, C., Elander, N., Gasslander, T., Gawel, D. R., Gustafsson, M., Jörnsten, R., Lee, E. J., Li, X., Lilja, S., Martínez-Enguita, D., Matussek, A., Sandström, P., Schäfer, S., Stenmarker, M., Sun, X. F., Sysoev, O., Zhang, H., & Benson, M.
Affiliations
  • Lund University (SE)
  • Linköping University (SE)
  • Chalmers University of Technology (SE)
  • Karolinska University Hospital (SE)
  • Futurum - Akademin för Hälsa och Vård (SE)
Corresponding author
Benson, Mikael
Venue
Genome Medicine
Published
2019-12-31
Volume
12
Issue
1
Pages
4-4
ISSN
1756-994X (ISSN-L)
OpenAlex
W2999365564
Cited by
566
References
9
Citations by year
2026: 143 · 2025: 126 · 2024: 103 · 2023: 79 · 2022: 66 · 2021: 37 · 2020: 12
FWCI
19.56
Type
journal article
Language
en
Open access
Locations
  • Genome Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DiVA (Linkoping University) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Lund University Publications (Lund University) (submittedVersion)
  • Chalmers Research (Chalmers University of Technology) (submittedVersion)
Funders
Swedish Cancer Foundation
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
Keywords
digital twin, personalized medicine, patient modeling, drug repurposing, computational drug screening, precision medicine, data integration
MeSH terms
Disease, Humans, Databases, Factual, Neural Networks, Computer, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review